Catalyst Wire Dossier Catalyst Wire Dossier

IDX719

NS5A inhibitor · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IDX719, covering 2015-04-27 to 2016-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004) [Phase 1]

See pricing